Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

FDA PMA

Prostrate cancer genes nucleic acid amplification test system

Número do PMA: P100033 · 2020-07-21

RequerenteGen-Probe Incorporated
Data da decisão2020-07-21
Número PMAP100033
Código do produtoOYM
Classe do DispositivoClasse 3
Especialidade MédicaU
Comité consultivoPA

Resumo do dispositivo

Prostrate cancer genes nucleic acid amplification test system is the device name listed in this FDA 510(k) record. The listed applicant is Gen-Probe Incorporated. It received FDA 510(k) clearance on 2020-07-21. The device is classified under product code OYM. It was reviewed by the PA advisory panel.

Perguntas frequentes

What is the Prostrate cancer genes nucleic acid amplification test system?

Prostrate cancer genes nucleic acid amplification test system is a medical device that received FDA 510(k) clearance on 2020-07-21. The listed applicant is Gen-Probe Incorporated.

When did Prostrate cancer genes nucleic acid amplification test system receive FDA 510(k) clearance?

The clearance date for Prostrate cancer genes nucleic acid amplification test system can be found in the official FDA records.

Who is the listed applicant for Prostrate cancer genes nucleic acid amplification test system?

The FDA 510(k) record lists Gen-Probe Incorporated as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Prostrate cancer genes nucleic acid amplification test system?

The FDA product code for Prostrate cancer genes nucleic acid amplification test system is OYM.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.

↑